Modification of antimicrobial prophylaxis based on rectal culture results to prevent fluoroquinolone-resistant Escherichia coli infections after prostate biopsy

Infection Control and Hospital Epidemiology

Volumn 34, Issue 9, 2013, Pages 973-976

  Suwantarat, Nuntra ^a   Dumford III, Donald M ^a   Ponce Terashima, Rafael ^a   Kundrapu, Sirisha ^a   Zabarsky, Trina F ^b   Zhu, Hui ^b   Donskey, Curtis J ^b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN; CIPROFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ESCHERICHIA COLI INFECTION; FEMALE; HUMAN; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROSTATE BIOPSY; TRANSRECTAL ULTRASONOGRAPHY;

AGED; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BIOPSY; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI INFECTIONS; FLUOROQUINOLONES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSTATE; RECTUM;

EID: 84881166082     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/671734     Document Type: Article

References (10)

1. Loeb S, Carter HB, Berndt SI, Ricker W, Shaeffer EM. Complications after prostate biopsy: data from SEER-Medicine. JUrol 2011;186:1830-1834.
2. Williamson DA, Barrett LK, Rogers BA, Freeman JT, Hadway P, Paterson DL. Infectious complications following transrectal ultrasound-guided prostate biopsy: new challenges in the era of multidrug-resistant Escherichia coli. Clin Infect Dis 2013;57:267-274.
3. Wolf JS Jr, Bennett CJ, Dmochowski RR, Hollenbeck BK, Pearle MS, Shaeffer AJ; Urologic Surgery Antimicrobial Prophylaxis Best Practice Policy Panel. Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol 2008;179: 1379-1390.
4. Feliciano J, Teper E, Ferrandino M, et al. The incidence of fluoroquinolone resistant infections after prostate biopsy: are fluoroquinolones still effective prophylaxis? J Urol 2008;179:952-955.
5. Liss MA, Chang A, Santos R, et al. Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients under- going transrectal ultrasound guided prostate needle biopsy. J Urol 2011;185:1283-1288.
6. Dumford DM III, Suwantarat N, Bhasker V, Kundrapu S, Drawz P, Donskey CJ. Outbreak of fluoroquinolone-resistant Esche- richia coli infections after transrectal ultrasound-guided prostate biopsy. Infect Control Hosp Epidemiol 2013;34:269-273.
7. Taylor AK, Zembower TR, Nadler RB, et al. Targeted antimicrobial prophylaxis using rectal swab cultures in men under- going transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care. J Urol 2012;187:1275-1279.
8. Duplessis CA, Bavaro M, Simons MP, et al. Rectal cultures before transrectal ultrasound-guided prostate biopsy reduce post-prostatic biopsy infection rates. Urology 2012;79:556-563.
9. Adibi M, Hornberger B, Bhat D, Raj G, Roehrborn CG, Lotan Y. Reduction in hospital admission rates due to post-prostate biopsy infections after augmenting standard antibiotic prophy-laxis. J Urol 2013;189:535-540.
10. Batura D, Rao GG, Bo Nielsen P, Charlett A. Adding amikacin to fluoroquinolone-based antimicrobial prophylaxis reduces prostate biopsy infection rates. BJU Int 2011;107:760-764.